Westlake Chemical Partners LP (WLKP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 200M 400M 600M Q3 '21: 294M Q4 '21: 330.5M Q1 '22: 362.4M Q2 '22: 448.8M Q3 '22: 415.1M Q4 '22: 366.8M Q1 '23: 307.7M Q2 '23: 264.2M Q3 '23: 321.7M Q4 '23: 297.3M Q1 '24: 284.7M Q2 '24: 284.2M Q3 '24: 277M Q4 '24: 290.1M Q1 '25: 237.6M Q2 '25: 297.1M Q3 '25: 308.9M Q4 '25: 323M Q1 '26: 305.7M Q2 '26: 297.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q3 '21: 75.9M Q4 '21: 147.1M Q1 '22: 91.4M Q2 '22: 97.3M Q3 '22: 90.5M Q4 '22: 98.1M Q1 '23: 106.1M Q2 '23: 87.7M Q3 '23: 93M Q4 '23: 100.7M Q1 '24: 102.2M Q2 '24: 101.2M Q3 '24: 116.9M Q4 '24: 98.6M Q1 '25: 54.1M Q2 '25: 97.5M Q3 '25: 99.4M Q4 '25: 96.8M Q1 '26: 93.8M Q2 '26: 94.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 50M 100M 150M Q3 '21: 68.1M Q4 '21: 140.8M Q1 '22: 83.2M Q2 '22: 87.4M Q3 '22: 81.8M Q4 '22: 95.3M Q1 '23: 98.2M Q2 '23: 80.5M Q3 '23: 86.2M Q4 '23: 92.8M Q1 '24: 95.1M Q2 '24: 93.6M Q3 '24: 109.7M Q4 '24: 92M Q1 '25: 46.6M Q2 '25: 91.2M Q3 '25: 92M Q4 '25: 89.8M Q1 '26: 86.6M Q2 '26: 87.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 15M 30M 45M Q3 '21: 12.8M Q4 '21: 29.5M Q1 '22: 16.2M Q2 '22: 16.4M Q3 '22: 14.8M Q4 '22: 16.8M Q1 '23: 14.9M Q2 '23: 11.9M Q3 '23: 13.2M Q4 '23: 14.3M Q1 '24: 14.8M Q2 '24: 14.4M Q3 '24: 18.1M Q4 '24: 15M Q1 '25: 4.9M Q2 '25: 14.6M Q3 '25: 14.7M Q4 '25: 14.5M Q1 '26: 14.2M Q2 '26: 14.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '21: 218M Q4 '21: 183.4M Q1 '22: 271M Q2 '22: 351.5M Q3 '22: 324.6M Q4 '22: 268.7M Q1 '23: 201.6M Q2 '23: 176.5M Q3 '23: 228.7M Q4 '23: 196.6M Q1 '24: 182.5M Q2 '24: 182.9M Q3 '24: 160.1M Q4 '24: 191.5M Q1 '25: 183.5M Q2 '25: 199.6M Q3 '25: 209.5M Q4 '25: 226.2M Q1 '26: 211.9M Q2 '26: 202.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

0 50M 100M 150M Q3 '21: 99.5M Q4 '21: 21.9M Q1 '22: 104.8M Q2 '22: 120.9M Q3 '22: 115.5M Q4 '22: 122.6M Q1 '23: 144.9M Q2 '23: 98.5M Q3 '23: 100.9M Q4 '23: 107.7M Q1 '24: 104.6M Q2 '24: 121.9M Q3 '24: 126.1M Q4 '24: 132.5M Q1 '25: 45.8M Q2 '25: 9.1M Q3 '25: 105.2M Q4 '25: 120.4M Q1 '26: 110.2M Q2 '26: 129.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-50M 0 50M 100M 150M Q3 '21: 88.3M Q4 '21: -20.8M Q1 '22: 84.5M Q2 '22: 108.9M Q3 '22: 102.4M Q4 '22: 113.9M Q1 '23: 132.2M Q2 '23: 94M Q3 '23: 84.1M Q4 '23: 94.8M Q1 '24: 94.8M Q2 '24: 111.7M Q3 '24: 110.5M Q4 '24: 119M Q1 '25: 29.8M Q2 '25: -15.3M Q3 '25: 75.6M Q4 '25: 111.5M Q1 '26: 104.6M Q2 '26: 117.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '15: 1.38 Q4 '15: 1.47 Q3 '15 Q4 '15

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.